Genome Web Breaking News
- Guardant Health Prices $319.5M Public Stock Offering
- Anxiety GWAS, Mouse Model Experiments Lead to Potential New Drug Target
- Genetic Technologies Offers $1.2M in American Depository Shares
- Adventist Health to Integrate CancerIQ Decision Support Into EHR
- NeoGenomics Prices $149M Public Offering of Common Stock
Stat
- STAT Plus: Novartis CEO coy about pricing its gene therapy for spinal muscular atrophy
- STAT Plus: Pharmalittle: Novartis to price gene therapy ‘far lower’ than $4m; advocates press WHA on transparency resolution
- Opinion: Prejudice and patient choice: an insidious confluence in medicine
- STAT Plus: Did FDA unfairly treat Catalyst by approving a similar drug from another company?
- STAT Plus: Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?
NYT science news
- There’s Evidence on How to Raise Children, but Are Parents Listening?
- Dr. Leonard Bailey, Who Gave a Baby a Baboon’s Heart, Dies at 76
- Can Trump Put NASA Astronauts on the Moon by 2024? It’s Unlikely
- Trilobites: ‘Battle of the Thermostat’: Cold Rooms May Hurt Women’s Productivity
- How Did Life Arrive on Land? A Billion-Year-Old Fungus May Hold Clues
Xconomy news
- Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D
- Cala Health Secures $50M to Launch Anti-Tremor Wrist Device
- WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
- Former Arsanis CEO René Russo Tapped to Lead Akrevia Therapeutics
- Celsius Therapeutics Adds Greg Ryslik and Michael Boretti to C-Suite
Fierce Biotech
- Nektar unveils Inheris Biopharma, its new CNS-focused offshoot
- EuroBiotech Report—Novartis-GSK, Affimed U-turn, Amgen-Nuevolution, Roche and VC fund raises cash
- Miniature livers reveal behavior of common cancer-causing gene mutation
- EuroBiotech: More Articles of Note
- Fountain Healthcare raises €118M for EU-focused fund
Fierce Medical Devices
- That was fast: Ex-FDA commish goes back to biotech investing
- Google’s cancer-spotting AI outperforms radiologists in reading lung CT scans
- Spire Health launches COPD study with its machine-washable wearable
- Novartis, Otsuka, Pfizer, Sanofi join Verily's Project Baseline
- Ocular's sustained-release insert misses bull's-eye in phase 3 glaucoma trial